A. Usul Et Al. , "Circulating interleukin-18 (IL-18) is a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma.," Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy , vol.23, pp.196-200, 2017
Usul, A. Et Al. 2017. Circulating interleukin-18 (IL-18) is a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma.. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy , vol.23 , 196-200.
Usul, A., KARABULUT, M., KARABULUT, S., ALıS, H., GONENC, M., DAGOGLU, N., ... SERILMEZ, M.(2017). Circulating interleukin-18 (IL-18) is a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma.. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy , vol.23, 196-200.
Usul, ÇİĞDEM Et Al. "Circulating interleukin-18 (IL-18) is a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma.," Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy , vol.23, 196-200, 2017
Usul, ÇİĞDEM U. Et Al. "Circulating interleukin-18 (IL-18) is a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma.." Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy , vol.23, pp.196-200, 2017
Usul, A. Et Al. (2017) . "Circulating interleukin-18 (IL-18) is a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma.." Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy , vol.23, pp.196-200.
@article{article, author={ÇİĞDEM USUL AFŞAR Et Al. }, title={Circulating interleukin-18 (IL-18) is a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma.}, journal={Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy}, year=2017, pages={196-200} }